John Wallenman
Analyst
Citizens
Equibles does not estimate personal net worth.
About John Wallenman
John Wallenman is recorded as Analyst at Citizens. John Wallenman has spoken on 1 earnings call across 1 company, most recently for Ocular Therapeutix, Inc on May 5, 2026. The companies whose calls John Wallenman spoke on are classified in the Healthcare sector.
John Wallenman on recent calls
“Just wondering, Praveen, if you could talk a little bit about the feedback you've received and how retina specialists plan on potentially integrating XPAXLY in the practice based on SOL1 and how that might change with the SOLAR readouts?”
Affiliation history
-
Citizens
Analyst
Transcript header (unverified)
Current